© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 17, 1292,
September 5, 2001
© 2001 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The National Center for Complementary and Alternative Medicine at the National Institutes of Health has made several recent appointments.Jane F. Kinsel, Ph.D., was appointed associate director for Science Policy and Operations within NCCAM. Kinsel will serve as senior adviser to NCCAM’s director on science, science policy and other strategic issues, as well as oversee the planning for and evaluation of the center’s scientific initiatives and operating programs.
Martin H. Goldrosen, Ph.D., was appointed chief of the Office of Scientific Review at NCCAM. The office is responsible for the peer review of all grant applications assigned to NCCAM.
Goldrosen will direct the activities of personnel within the Office to ensure quality, objectivity, and accountability in the grants and contracts peer review process.
Joana Rosario, M.D., was appointed the first international program director of NCCAM.
Rosario will develop a long-range plan for CAM research on a global scale and will direct and oversee a multifaceted international portfolio of research grants and contracts involving the safety, efficacy, and mechanisms underlying diverse CAM modalities.
UCSD Designated
The National Cancer Institute has designated the University of California at San Diego Cancer Center as a Comprehensive Cancer Center.
Including UCSD, there are 41 cancer centers nationwide that carry the NCI Comprehensive Cancer Center designation. The title signifies that UCSD Cancer Center covers a full range of cancer research activities, including basic and clinical science, population studies, community outreach programs and cancer-prevention activities.
Slavin Named
Shimon Slavin, M.D., director of Israel’s National Bone Marrow Transplant Center, has been named Medical Director of Immunotherapy to initiate new protocols for bone marrow transplant at Cancer Treatment Centers of America, Arlington Heights, Ill., and its five cancer centers.
Cancer Treatment Centers of America manages cancer hospitals, oncology practices and outpatient hospital-based cancer programs.
Slavin is also the director of the Cancer Immunotherapy and Immunobiology Research Center at Hadassah University, Israel, and has been Chairman of the Sidney Weisner Department of the Bone Marrow Transplantation Center at Hadassah since 1980.
Proposals Being Accepted
The Lymphoma Research Foundation of America is accepting research proposals for Fellowship Grants and Junior Faculty Grants.
Fellowship Research Grants provide up to $45,000 per year for salary (including fringe benefits) and are available to researchers working on lymphoma-specific studies. Applicants must hold a Ph.D., M.D., or equivalent degree. An applicant who holds an M.D. must be at least a third year fellow.
The Junior Faculty Grant is for researchers with assistant or associate professor standing. This grant awards up to $75,000 in support of projects led by investigators who have a proven history of research specific to lymphoma.
In addition, the LRFA is making a special request for mantle cell research projects that would be funded by the Irving Granet Mantle Cell Fund, which is administered by the Foundation.
Applications must be postmarked on or before Nov. 15, 2001. Research grants are awarded annually. The funding year commences on July 1, 2002, and ends June 30, 2003.
For policies and grant applications, visit LRFA’s Web site at http://www.lymphoma.org, or write, fax or e-mail: Lymphoma Research Foundation of America, 8800 Venice Blvd., Suite 207, Los Angeles, CA 90034, Attn: Research Grants Administrator, Fax: 310-204-7043, ResearchGrants{at}lymphoma.org.
Nominations Sought
Coping, a magazine for cancer patients and families and friends of cancer patients, is accepting nominations for Cancer Survivor of the Year.
The magazine will choose someone who "best represents the spirit of the international cancer community," said Mike Holt, the magazine’s publisher.
The winner will be featured in Coping’s January/February 2002 issue and will receive a $1,000 cash award. The award program is funded by an educational grant from Aventis Pharmaceuticals.
Nomination letters should be 1200 words and include a color photograph of the nominee, along with the nominee’s name, telephone number, and address. Nominations must be postmarked by Oct. 1, 2001, and sent to: Survivor of the Year, P.O. Box 682268, Franklin, TN, 37068-2268.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||